NM_006393.3:c.2997A>G

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The NM_006393.3(NEBL):​c.2997A>G​(p.Thr999Thr) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0765 in 1,613,892 control chromosomes in the GnomAD database, including 5,309 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).

Frequency

Genomes: 𝑓 0.086 ( 635 hom., cov: 32)
Exomes 𝑓: 0.076 ( 4674 hom. )

Consequence

NEBL
NM_006393.3 synonymous

Scores

2

Clinical Significance

Benign/Likely benign criteria provided, multiple submitters, no conflicts B:6

Conservation

PhyloP100: 0.181

Publications

14 publications found
Variant links:
Genes affected
NEBL (HGNC:16932): (nebulette) This gene encodes a nebulin like protein that is abundantly expressed in cardiac muscle. The encoded protein binds actin and interacts with thin filaments and Z-line associated proteins in striated muscle. This protein may be involved in cardiac myofibril assembly. A shorter isoform of this protein termed LIM nebulette is expressed in non-muscle cells and may function as a component of focal adhesion complexes. Alternate splicing results in multiple transcript variants. [provided by RefSeq, Mar 2010]
NEBL Gene-Disease associations (from GenCC):
  • dilated cardiomyopathy
    Inheritance: AD Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.63).
BP6
Variant 10-20785795-T-C is Benign according to our data. Variant chr10-20785795-T-C is described in ClinVar as [Likely_benign]. Clinvar id is 45497.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.181 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.116 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NEBLNM_006393.3 linkc.2997A>G p.Thr999Thr synonymous_variant Exon 28 of 28 ENST00000377122.9 NP_006384.1 O76041-1Q59FZ8

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NEBLENST00000377122.9 linkc.2997A>G p.Thr999Thr synonymous_variant Exon 28 of 28 1 NM_006393.3 ENSP00000366326.4 O76041-1

Frequencies

GnomAD3 genomes
AF:
0.0856
AC:
13018
AN:
152124
Hom.:
634
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.119
Gnomad AMI
AF:
0.0384
Gnomad AMR
AF:
0.109
Gnomad ASJ
AF:
0.0922
Gnomad EAS
AF:
0.00192
Gnomad SAS
AF:
0.0543
Gnomad FIN
AF:
0.0524
Gnomad MID
AF:
0.0854
Gnomad NFE
AF:
0.0746
Gnomad OTH
AF:
0.0722
GnomAD2 exomes
AF:
0.0800
AC:
20073
AN:
250986
AF XY:
0.0756
show subpopulations
Gnomad AFR exome
AF:
0.123
Gnomad AMR exome
AF:
0.156
Gnomad ASJ exome
AF:
0.0946
Gnomad EAS exome
AF:
0.000708
Gnomad FIN exome
AF:
0.0544
Gnomad NFE exome
AF:
0.0730
Gnomad OTH exome
AF:
0.0808
GnomAD4 exome
AF:
0.0756
AC:
110490
AN:
1461650
Hom.:
4674
Cov.:
31
AF XY:
0.0746
AC XY:
54248
AN XY:
727130
show subpopulations
African (AFR)
AF:
0.120
AC:
3999
AN:
33462
American (AMR)
AF:
0.148
AC:
6608
AN:
44708
Ashkenazi Jewish (ASJ)
AF:
0.0960
AC:
2509
AN:
26130
East Asian (EAS)
AF:
0.00176
AC:
70
AN:
39682
South Asian (SAS)
AF:
0.0587
AC:
5063
AN:
86258
European-Finnish (FIN)
AF:
0.0539
AC:
2880
AN:
53410
Middle Eastern (MID)
AF:
0.0830
AC:
478
AN:
5762
European-Non Finnish (NFE)
AF:
0.0756
AC:
84093
AN:
1111858
Other (OTH)
AF:
0.0793
AC:
4790
AN:
60380
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
5721
11441
17162
22882
28603
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
3178
6356
9534
12712
15890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0855
AC:
13017
AN:
152242
Hom.:
635
Cov.:
32
AF XY:
0.0845
AC XY:
6286
AN XY:
74428
show subpopulations
African (AFR)
AF:
0.119
AC:
4921
AN:
41518
American (AMR)
AF:
0.109
AC:
1664
AN:
15290
Ashkenazi Jewish (ASJ)
AF:
0.0922
AC:
320
AN:
3472
East Asian (EAS)
AF:
0.00193
AC:
10
AN:
5188
South Asian (SAS)
AF:
0.0541
AC:
261
AN:
4820
European-Finnish (FIN)
AF:
0.0524
AC:
557
AN:
10624
Middle Eastern (MID)
AF:
0.0918
AC:
27
AN:
294
European-Non Finnish (NFE)
AF:
0.0746
AC:
5072
AN:
68010
Other (OTH)
AF:
0.0710
AC:
150
AN:
2114
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
608
1217
1825
2434
3042
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
150
300
450
600
750
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.0894
Hom.:
693
Bravo
AF:
0.0923
Asia WGS
AF:
0.0330
AC:
116
AN:
3478
EpiCase
AF:
0.0761
EpiControl
AF:
0.0759

ClinVar

Significance: Benign/Likely benign
Submissions summary: Benign:6
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Mar 19, 2012
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

p.Thr999Thr in Exon 28 of NEBL: This variant is not expected to have clinical si gnificance because it does not alter an amino acid residue, is not located withi n the splice consensus sequence and has been identified in 12.4% (462/3738) of A frican American chromosomes from a broad population by the NHLBI Exome Sequencin g Project (http://evs.gs.washington.edu/EVS; dbSNP rs2296614). -

Apr 10, 2023
Women's Health and Genetics/Laboratory Corporation of America, LabCorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Jan 17, 2014
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

May 17, 2022
Ambry Genetics
Significance:Likely benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Primary dilated cardiomyopathy Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.63
CADD
Benign
1.1
DANN
Benign
0.59
PhyloP100
0.18
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2296614; hg19: chr10-21074724; API